In medial calcification, the contractile vascular smooth muscle cells (VSMCs) undergo osteogenic differentiation under the influence of hyperphosphataemia, secondary hyperparathyroidism, and advanced glycation end products, which activate the transcription factor for osteoblastic differentiation, RunX2. Here, RUNX2 is linked to hyperphosphatemia.